Cognitive Training to Enhance Brain Concordance During Acupuncture
Cognitive Training to Enhance Brain-to-brain Concordance During Acupuncture
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Arvina Grahl, PhD
- Email: agrahl@mgh.harvard.edu
Study Contact Backup
- Name: Seneca Ellis
- Phone Number: 617-952-6484
- Email: sellis11@mgb.org
Study Locations
-
-
Massachusetts
-
Charlestown, Massachusetts, United States, 02129
- Recruiting
- Massachusetts General Hospital
-
Contact:
- Seneca Ellis
- Phone Number: 617-952-6484
- Email: sellis11@mgb.org
-
Contact:
- Lara Gardiner
- Phone Number: 617-952-6483
- Email: lgardiner1@mgb.org
-
Charlestown, Massachusetts, United States, 02129
- Recruiting
- Spaulding Rehabilitation Hospital
-
Contact:
- Seneca Ellis
- Phone Number: 617-952-6484
- Email: sellis11@mgb.org
-
Contact:
- Lara Gardiner
- Phone Number: 617-952-6483
- Email: lgardiner1@mgb.org
-
Principal Investigator:
- Vitaly Napadow, PhD
-
Chestnut Hill, Massachusetts, United States, 02467
- Recruiting
- Brigham and Women's Hospital
-
Sub-Investigator:
- Robert Edwards, PhD
-
Contact:
- Seneca Ellis
- Phone Number: 617-952-6484
- Email: sellis11@mgb.org
-
Contact:
- Lara Gardiner
- Phone Number: 617-952-6483
- Email: lgardiner1@mgb.org
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Meet traditional American College of Rheumatology (ACR) criteria for FM as well as the more recent Wolfe et al 2011 criteria
- Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
- Ability to fully understand and consent to study procedures
- Baseline pain intensity of at least 4/10
- Pain duration of at least 6 months
Exclusion Criteria:
- Any longer period of work experience involving pain treatment, pain rehabilitation etc.
- Presence of any illness that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual
- Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy.
- History of significant head injury
- Inability to respond accurately to the pain-relieving intervention in the behavioral part of the experiment, indicating a lack of response to the expectancy manipulation. If the healthy volunteer or clinician is not a responder to the behavioral expectancy induction he or she will be excluded.
- Unwillingness to receive brief experimental pain.
- Leg pain or health issues that may interfere with the study procedures.
- Comorbid acute pain condition
- Comorbid chronic pain condition that is rated by the subject as more painful than fibromyalgia
- Current use of opioid analgesics
- Concurrent inflammatory or autoimmune disease
- Documented peripheral neuropathy
- Pregnant
- Any psychiatric disorder involving a history of psychosis (e. g schizophrenia, bipolar disorder, severe personality disorders)
- History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
- Psychiatric hospitalization in the past 6 months
- Unwillingness to withhold from consuming marijuana 12 hours prior to scans
- Unwillingness to withhold from consuming nicotine 4 hours prior to scans
- Any impairment, activity or situation that in the judgment of the Study Coordinator or Principal Investigator would prevent satisfactory completion of the study protocol.
- Is an actual clinical patient of the clinician subject
- Recent history of formal meditation-based training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Cognitive Training
Participants will meet with a pain specialist who will conduct a specific form of cognitive training targeting fibromyalgia.
|
During the treatment sessions the acupuncturist will insert needles in several locations aimed to reduce the patient's fibromyalgia pain.
A low-amplitude, sub-sensory electrical current will be activated by the acupuncturist.
Cognitive training with a pain specialist.
|
|
Active Comparator: Education Training
Participants will meet with a pain specialist to receive education training related to fibromyalgia.
|
During the treatment sessions the acupuncturist will insert needles in several locations aimed to reduce the patient's fibromyalgia pain.
A low-amplitude, sub-sensory electrical current will be activated by the acupuncturist.
Education training with a pain specialist.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain Imaging-fMRI
Time Frame: Up to 6 months
|
Hyperscan fMRI assessing brain-to-brain concordance between the patient and the clinician.
|
Up to 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain Imaging-EEG
Time Frame: Up to 6 months
|
Hyperscan EEG assessing brain-to-brain concordance between the patient and the clinician.
|
Up to 6 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Pain Inventory (BPI) - Pain Interference
Time Frame: Up to 6 months
|
Brief Pain Inventory (BPI) is a validated 16 item questionnaire designed to assess the severity and interference of pain experienced.
Pain interference is assessed on a scale from 0 (no interference) to 10 (severe interference).
|
Up to 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Vitaly Napadow, PhD, Spaulding Rehabilitation Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Musculoskeletal Diseases
- Nervous System Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Rheumatic Diseases
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Fibromyalgia
- Chronic Pain
- Therapeutics
- Complementary Therapies
- Physical Therapy Modalities
- Patient Care
- Health Services
- Health Care Facilities Workforce and Services
- Behavioral Disciplines and Activities
- Rehabilitation
- Aftercare
- Continuity of Patient Care
- Anesthesia and Analgesia
- Electric Stimulation Therapy
- Neurological Rehabilitation
- Combined Modality Therapy
- Sexology
- Behavioral Sciences
- Anesthesia
- Analgesia
- Acupuncture Therapy
- Transcutaneous Electric Nerve Stimulation
- Cognitive Training
- Sex Education
- Electroacupuncture
Other Study ID Numbers
Other Study ID Numbers
- 2023P003155
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.